agilon health, inc. Cash and Restricted Cash
agilon health, inc. (AGL) had Cash and Restricted Cash of $178.81 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $178.81M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $211.57M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $173.71M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $171.68M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $178.81M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $211.57M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $173.71M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $171.68M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $171.42M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $138.62M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $193.86M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $153.79M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $116.34M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $118.55M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $114.33M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $169.66M 10-Q · filed 2024-11-07 | $178.54M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $184.55M 10-Q · filed 2024-08-06 | $201.19M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $397.02M 10-Q · filed 2024-05-07 | $404.39M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $475.91M 10-K · filed 2026-02-25 | $507.68M 10-K · filed 2023-03-01 |
| 2022-09-30 | $564.48M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $683.66M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $1.04B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.05B 10-K · filed 2025-02-25 | $1.05B 10-K · filed 2022-03-03 |
| 2021-09-30 | $1.10B 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $1.13B 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $119.49M 10-Q · filed 2021-05-26 | |
| 2020-12-31 | $128.20M 10-K · filed 2024-02-27 | $135.18M 10-Q · filed 2021-05-26 |
| 2020-09-30 | $126.49M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $134.55M 10-Q · filed 2021-08-04 | |
| 2020-03-31 | $142.56M 10-Q · filed 2021-05-26 | |
| 2019-12-31 | $139.15M 10-K · filed 2023-03-01 | |
| 2018-12-31 | $76.41M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |